Molecular Metabolism·Nov 4Discovery, optimization, and Phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonistNon-randomized trial in peopleGLP-1 receptor agonistsPaper
Pharmaceutics·Nov 2A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin PenetrationExperiments in miceSemaglutidePaper
Journal of Controlled Release·Feb 12Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide deliveryExperiments in ratsSemaglutidePaper